Explore Events
The Alliance for Health Policy is a nonpartisan, nonprofit organization dedicated to helping policymakers and the public better understand health policy, the root of the nation’s health care issues, and the trade-offs posed by various proposals for change.
Upcoming Events
Explore our curated selection of American health care events, designed to inspire and inform as you navigate the ever-evolving landscape of medical advancements and policy changes.
Join Our Event List
Join our event newsletter to stay up to date on our latest events and webinars.
Signature Series
Courageous Conversations. Innovative Events.
The annual Signature Series addresses challenging issues in health policy by convening cross-sector dialogue with experts in both policy and practice. Together, we critically examine and identify what’s at stake, as well as key areas of opportunity.
This year’s theme focuses on the transformative power of Artificial Intelligence (AI) in health care and health policy.
Past Events
Filter Past Events
Research shows that approximately 40 percent of former federal prisoners and over 60 percent of former state prisoners are rearrested within three years of release and many are re-incarcerated. Individuals transitioning into and out of the criminal justice system include many low-income adults with significant physical and mental health needs. Through outreach and education, correctional […]
In 2014, there were a total of 1,299 mergers and acquisitions in the health care sector – a record number, up from 1,035 the year before. This briefing will discussed the driving forces behind this recent increase in consolidation; the scope and extent of consolidation among doctors, hospitals and insurers; implications for consumers and other […]
Evidence shows that medication adherence—the extent to which a person takes medications as prescribed by their health care providers—is associated with improved health care outcomes for many costly chronic conditions, including heart disease, diabetes, and asthma. However, only 50% percent of Americans are estimated to take their medications as prescribed, and non-adherence is estimated to […]
Behavioral health conditions, including mental health issues and substance use disorders, affect nearly one in five Americans and account for $57 billion in health care costs annually. This briefing discussed current initiatives to integrate behavioral and physical health care services in order to improve quality of care and reduce overall health care costs. KEY BRIEFING […]
With Medicare Advantage (Part C) and prescription drug (Part D) open enrollment beginning October 15th, this briefing took a close look at what to expect, including trends in premiums and cost sharing, plan availability and benefit design. The day following the briefing, Medicare beneficiaries will be able to enroll in the Medicare Advantage and prescription drug […]
The movement toward home and community-based, long-term services and supports (LTSS) continues to grow, resulting in increased demand for these services. The goal is to help people live in the community independently, yet many barriers to offering HCBS still exist. This briefing will examine the potential of HCBS to reduce health care costs and improve […]
With the third open enrollment period for health insurance marketplaces launching November 1st, this briefing took a detailed look at what consumers can expect regarding premiums, health plan availability and affordability. Speakers provided the latest information about premium trends and drivers, health plan availability and new tools designed to help consumers make informed choices. They highlighted changes from […]
This briefing, the third in a series on creating a more consumer-friendly and patient-centered health care system, delved into the issues that patients face as they make decisions about their health care. It explored questions such as: What does it mean for patients to be engaged in their care? What information and tools are available to empower […]
Innovative drugs have brought about significant progress in treating costly and complex conditions. While there is agreement among many stakeholders that some of these breakthrough drugs have had a positive impact on Americans’ health and life expectancy, increasing prices have also caused some confusion about the methods by which drug prices are determined. The […]